Veterinary

Regulation (EU) 2019/6 provides standards for veterinary medical products (VMPs) in the European Union, ensuring the protection of human and animal health as well as the environment. A marketing authorisation is required for any product placed on the market, and companies must provide a data dossier to support their application; the pharmacologically active substance must be approved and listed. The EU registration process ensures that only items that meet a specific standard and have been extensively tested and examined by independent experts are allowed to enter the market.

The application for marketing authorization must include all scientific documents required to demonstrate the VMP’s quality, safety, and efficacy.

Insect repellents and products applied topically to disinfect teats and udders are examples of products for animal usage that fall beyond the scope of these regulations. They, like disinfectants used in animal housing, are regulated by the Biocidal Products Regulation.

For many years, Maven scientists have provided experienced help to companies working in the active substance sector, whether it’s pharmaceuticals, veterinary products, or biocides. The toxicological concerns provided by non-active components of any formulation – excipients, processing aids, and manufacturing impurities – are particularly sought after. We are your ideal partner to support your veterinary product registration with our extensive skills in chemical hazard and risk assessment, data searching, exposure modelling, and extensive use ofthe threshold of toxicological concern (TTC)and the concepts of structure-activity relationships (SARs).